60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc stock is traded at $0.9164, with a volume of 41,955. It is down -4.17% in the last 24 hours and down -17.44% over the past month. 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.